Category Archives: Advertising
The HCR Taxman Cometh
By Tom Norton
As the country struggles with the current economic malaise, and the pharmaceutical industry enters into yet another difficult quarter of “trying to make the numbers,” one matter that I doubt many Rx execs are thinking about today is the HCR Taxman. That’s too bad. They probably should. That’s because he’s coming for the [...]
Also posted in Agency Insight, Biotech, Corporate Responsibility, Strategy, compliance Comments closed
Without An Rx, Some Pharmas Are Skittish
Lower margins and strong-arm direct-to-consumer campaigns are two of the primary barriers to selling nutraceuticals, according to a business school ‘war game’ conducted with the participation of Abbott, Danone (Dannon in the US), GSK and Nestlé. But the global nutraceuticals market – worth $80 billion in 2010, according to Frost & Sullivan – is expected [...]
Also posted in Global, IP, Marketing, Regulatory, Strategy, patient education Tagged Abbott, Consumer Advertising, GlaxoSmithKline, Nutraceuticals 4 Comments
DIA: Social Media Guidelines are DDMAC’s "Highest Priority"
Tom Abrams, director of FDA’s Division (soon to be Office) of Drug Marketing, Advertising & Communications (DDMAC), said that publishing social media guidelines for industry is the division’s “highest priority,” and that the document will be “published as soon as it’s vetted.”
Also posted in E-Media, FDA, Marketing, Meetings, Regulatory, Strategy, Technology, patient education, social media Tagged DDMAC, DIA, Tom Abrams 1 Comment
Pharma “Channels” Patient Engagement
New disease-specific television networks shown in physicians’ offices provide education for patients and advertising at the point of contact for pharma companies.
What if pharma companies had one last chance to reach patients, just before they walked into the exam room to speak to their physicians? What if the very last word a patient heard before [...]
Also posted in Marketing, Patient Communication, Technology, healthcare, patient education Leave a comment

Pfizer CEO: DTC a 'Fundamental Right'